Atrioventricular Nodal Reentry Tachycardia (AVNRT)

Atrioventricular Nodal Reentry Tachycardia (AVNRT)

Melvin M. Scheinman, M.D., F.A.C.P.
University of California, San Francisco, School of Medicine

Definition/Key Clinical Features
Differential Diagnosis
Best Tests
Best Therapy
Best References

Definition/Key Clinical Features


back to top
Differential Diagnosis
back to top
Best Tests
  • 12-lead ECG
    • The P wave is either buried within the QRS complex or inscribed just after the QRS complex
  • The P wave inscribed by retroconduction over the AV node is negative in the inferior leads and positive in lead V1; PSVT may manifest as small negative deflections in the inferior leads and a small positive deflection in V1 (pseudo r¹ pattern)

back to top
Best Therapy


Acute Therapy

Nonpharmacologic

  • Carotid sinus massage
Pharmacologic

  • Adenosine: for use when carotid massage fails to convert SVT
    • Possible adverse effects: headache, wheezing, flushing, which will disappear within 45–60 sec; atrial, ventricular, and junctional premature beats; atrial fibrillation in 3% to 5% of cases, which may result in serious problems for patients with accessory pathways
    • An external defibrillator should be readily available when adenosine is administered
    • Dose: initial dose: rapid bolus of 6 mg I.V., followed by a saline flush; if necessary, a 12 mg dose and finally an 18 mg dose can be given
  • Metoprolol (5 mg I.V.) or verapamil (0.1 mg/kg I.V.) for patients who fail to respond to adenosine

Long-term Therapy

  • Associated with frequent recurrences and adverse effects
Pharmacologic

  • Beta blockers
  • Sotalol
    • Common side effects: torsade de pointes, heart failure, bradycardia, exacerbation of chronic obstructive or bronchospastic lung disease
    • Adjust dose for renal function and QT-interval response during in-hospital initiation phase
    • Dose: 240–320 mg/day
    • Cost/mo: $138
  • Calcium channel blockers (verapamil, diltiazem)
  • Digoxin
    • Dose: 0.1 mg/day
    • Cost/mo: $9
  • Antiarrhythmic agents: for patients without structural cardiac disease; more effective than beta blockers and calcium channel blockers, but with 25% to 35% recurrence rates
  • Amiodarone
    • Common side effects: photosensitivity, pulmonary toxicity, polyneuropathy, GI upset, bradycardia, torsade de pointes (rare), hepatic toxicity, thyroid dysfunction
    • Dose: 100–400 mg/day
    • Cost/mo: $94
  • Disopyramide
    • Common side effects: torsade de pointes, heart failure, glaucoma, urinary retention, dry mouth
    • Dose: 400–750 mg/day
    • Cost/mo: $84
  • Dofetilide
    • Common side effect: torsade de pointes
    • Dose: 500–1,000 mg/day
    • Cost/mo: N/A
  • Flecainide
    • Common side effects: ventricular tachycardia, heart failure, enhanced AV nodal conduction (conversion to atrial flutter)
    • Dose: 200–300 mg/day
    • Cost/mo: $115
  • Procainamide
    • Common side effects: torsade de pointes, lupuslike syndrome, GI symptoms
    • Dose: 1,000–4,000 mg/day
    • Cost/mo: $59
  • Propafenone
    • Common side effects: ventricular tachycardia, heart failure, enhanced AV nodal conduction (conversion to atrial flutter)
    • Dose: 490–900 mg/day
    • Cost/mo: $198
  • Quinidine
    • Common side effects: torsade de pointes, GI upset, enhanced AV nodal conduction
    • Dose: 600–1,500 mg/day
    • Cost/mo: $67
  • Single-dose agents for p.r.n. use: diltiazem, 120 mg, or propranolol, 80 mg; p.r.n. dosing regimens are used with caution and only after efficacy and safety have been established for the individual patient under ECG monitoring

Nonpharmacologic

  • Catheter ablation
    • Procedure of choice for patients in whom drug therapy fails and those with milder symptoms who prefer to avoid long-term drug therapy
    • Success rate > 96%
    • AV block occurs in ~ 1% of patients

back to top

Best References

Kwaku KF, et al: Card Electophysiol Rev 6:414, 2002

Jackman WM, et al: N Engl J Med 327:313, 1992

October 2004


back to top
© 2011 Decker Intellectual Properties. All rights reserved.